Austria spends more than €4 billion on research and development annually. A disproportionate share of this goes through a handful of programs that many early-stage life science startups either do not know about or apply to incorrectly. The founders who crack the Austrian funding system — combining FFG project grants with aws subsidised loans, building credibility through INiTS or LISAvienna acceleration, and timing Horizon Europe applications correctly — consistently outpace those who self-fund or rely solely on private venture capital. This is a practical guide to what is available, what each program actually funds, and how to combine them.
The Austrian Research Funding Landscape at a Glance
Austrian research funding operates across three distinct tiers, each serving a different stage and type of activity. Understanding which tier applies to your organisation is the first step to a successful application.
The federal agency tier is where most early-stage life science companies start. FFG (Forschungsförderungsgesellschaft) handles applied research — projects with a clear connection between scientific work and commercial outcomes. FWF (Fonds zur Förderung der wissenschaftlichen Forschung) funds basic research with no immediate commercial requirement, making it the natural home for academic spinoffs in the very earliest stages. aws (Austria Wirtschaftsservice) operates at the economic development layer — subsidised loans, equity co-investment, and founder advisory services rather than pure grants.
The EU programs tier opens up once a company has traction, validated data, and the capacity to manage a multi-national application process. Horizon Europe, the EIC Accelerator, and EIC Pathfinder are the primary instruments for Austrian biotech and medtech companies looking to scale internationally.
The regional and ecosystem tier provides acceleration, network access, and soft funding. LISAvienna serves the Vienna life science cluster. INiTS runs the flagship deep-tech accelerator at Vienna's university centres. BioRegio Steiermark supports Graz-based companies, and SFG (Steirische Wirtschaftsförderungsgesellschaft) provides regional co-funding for Steiermark companies.
The critical distinction within federal programs is between grant funding (non-repayable — FFG, FWF), subsidised loans (aws, repayable at below-market rates), and equity co-investment (aws Venture Capital and Gründerfonds, where aws takes a minority stake). LabWallio founders have navigated all three layers: the combination is almost always more effective than any single instrument alone.
FFG — Forschungsförderungsgesellschaft
FFG is Austria's central agency for applied research funding. For life science startups, three programs are directly relevant.
FFG COIN (Cooperation and Innovation) funds research cooperation between companies and universities or non-university research institutions. The typical grant range is €100,000 to €500,000 per project, with a co-funding rate of 40–70% of eligible costs. COIN is well-suited to life science startups that already have an academic collaboration in place or can establish one — the program explicitly rewards industry-academia partnerships.
FFG Bridge targets near-market research, again in a company-university collaboration structure. Grants of up to €600,000 are available for projects that bridge the gap between scientific discovery and commercial application — a stage where many Austrian medtech and diagnostics companies sit. The program is competitive but the application process is well-documented and FFG provides concept note feedback before formal submission.
FFG Basisprogramm is the most accessible entry point for first-time applicants. Critically, the company can apply alone — no academic partner is required. Grant amounts up to €300,000 per project are realistic, and the program covers a wide range of applied R&D activities. For a startup that does not yet have a university partnership formalised, this is the logical first FFG application.
Application timelines across all FFG programs run 6–8 months from initial concept note to first payment. Budget accordingly: plan the project start date at least eight months after you begin the application process. FFG also runs a pre-application advisory service; use it before submitting a concept note, not after.
One frequently overlooked point: equipment access costs — including fees for shared lab equipment — are eligible infrastructure costs in FFG project budgets. LabWallio sessions booked for a funded project can be included as budgeted infrastructure expense. Confirm eligibility with your FFG programme manager during the concept note phase; the answer is consistently yes when the access is project-specific and properly invoiced.
aws — Austria Wirtschaftsservice
aws operates differently from FFG: its instruments are primarily financial rather than research-focused, designed to reduce the cost of capital for innovative Austrian companies rather than directly fund specific research activities.
aws Gründerfonds provides early-stage equity investment of €500,000 to €2,000,000 for scalable technology companies with strong intellectual property protection. For life science startups, this typically means a patent or patent application is in place or in process. The Gründerfonds takes a minority equity stake and is structured as a financial co-investor alongside private lead investors.
aws Pre-Founding Check is a free 72-hour feasibility consultation available to any Austrian founder before formal application to aws programs. Every life science founder should use this before investing time in a full aws application. The response is candid about whether your project is fundable under current aws criteria and which specific programs are most relevant.
aws Double Equity is one of the most capital-efficient instruments available in Austria. For every euro of private venture capital raised, aws provides a matching subsidised loan — structured as quasi-equity. The effect is to reduce dilution significantly: a founder who raises €500,000 from private investors can access an additional €500,000 from aws at subsidised rates without issuing further equity. For capital-intensive life science hardware and diagnostics companies, this instrument is underutilised.
aws Innovationschutzpaket co-funds up to 50% of intellectual property registration costs, including patent filings, PCT applications, and CE marking preparatory work. For medtech and in-vitro diagnostics startups navigating MDR (Medical Device Regulation) compliance, this can cover a meaningful portion of regulatory costs in the early phase.
INiTS — Startup Acceleration for Deep Tech
INiTS (Universitätszentrum Wien GmbH) runs Austria's flagship deep-tech accelerator, supporting 20–30 teams per year across all technology domains, with life science and medtech consistently comprising the largest single category of accepted companies.
The 12-month program provides access to university labs and research infrastructure, mentors drawn from the Austrian pharma and medtech industry, structured connection to the LISAvienna network and its 350+ member companies, subsidised legal support for IP strategy and regulatory affairs (CE marking, clinical trial design), and introductions to Austrian and German-speaking venture capital. There is no equity taken by INiTS as a condition of program participation — the program is publicly subsidised and does not take a stake.
Application is via annual open call, typically with a deadline in spring for a summer start. For life science startups at the pre-seed or seed stage with a university connection (or recent spinoff from one), INiTS is the highest-leverage acceleration option in Austria. The network effects alone — access to LISAvienna and to the INiTS alumni community — are worth more than the cash equivalent of the services provided. More information and current open call dates at inits.at.
LISAvienna — The Life Science Cluster
LISAvienna is the life science cluster organisation for the Vienna region, representing more than 350 member companies across pharma, biotech, medtech, and diagnostics. For startups, LISAvienna provides a set of services that are difficult to replicate independently at the same cost.
The most immediately valuable are the free funding navigation advisory sessions: LISAvienna advisors map your company against current Austrian and EU funding programs, identify the most suitable programs for your stage and technology area, and provide introductions to relevant FFG and aws programme managers. This is not a generic overview — it is a structured analysis of your specific situation, done by people who have seen hundreds of similar companies go through the process.
LISAvienna also provides investor matching introductions, regulatory guidance for companies navigating CE marking and MDR compliance, access to Vienna BioCenter laboratory facilities for member companies, and representation in EU-level advocacy on life science funding and regulatory policy. Membership is available at multiple tiers; the entry tier for startups is subsidised and is worth the cost purely for the funding advisory access.
For startups outside Vienna: LISAvienna's national programs apply across Austria. Graz-based companies connect through the BioRegio Steiermark cluster, which has a formal cooperation with LISAvienna. Linz companies connect through JKU's technology transfer office and the OIC (Oberösterreichische Innovations Cluster) network. More at lisavienna.at.
Horizon Europe — The EU Funding Layer
Horizon Europe is the EU's primary research and innovation funding program, with a total budget of €95.5 billion for 2021–2027. For Austrian life science startups, two instruments are directly relevant.
EIC Accelerator provides grants of up to €2.5 million combined with optional equity investment of up to €15 million for breakthrough innovations with a clear path to market. This is the most ambitious instrument available to Austrian startups, and the most competitive: the acceptance rate sits below 5% of applications reaching the final interview stage. EIC Accelerator requires a demonstrated MVP, early market validation or clinical data, and a credible commercialisation pathway. Companies typically spend 12–18 months preparing a competitive application. Austrian companies have historically performed above the European per-capita average in EIC success rates.
EIC Pathfinder is designed for early-stage, high-risk deep science: projects that are exploring a new technological paradigm rather than advancing one toward market. Grants of up to €3 million are available, with a more exploratory mandate and less commercial pressure than the Accelerator. For life science companies at the discovery phase with a potentially transformative scientific approach, Pathfinder is the more appropriate instrument than Accelerator.
MSCA (Marie Skłodowska-Curie Actions) fund researcher mobility and training, making them particularly valuable for academic-industry collaborations. An Austrian startup with a university partner can use MSCA to fund a PhD researcher or postdoc working at the company, covering salary and overhead for 2–3 years. This is a highly underutilised instrument in the Austrian startup ecosystem.
Austria's Enterprise Europe Network (EEN Austria) provides free proposal support for Horizon Europe applications. Use this resource: the proposal quality difference between supported and unsupported applications is measurable, and the service is fully subsidised. Information at eic.ec.europa.eu.
Applying for FFG or aws funding? LabWallio issues project-coded invoices for equipment access sessions that meet FFG documentation standards. Join the waitlist to access lab instruments in Vienna from Q3 2026 — and include access costs in your project budget from day one.
The Equipment Gap — Where Funding Alone Is Not Enough
Even well-funded life science startups hit an infrastructure wall. Equipment costs consume 30–45% of early research budgets in instrument-intensive disciplines, and the distribution is highly uneven: a single flow cytometer or mass spectrometer can represent more capital than an entire year's staffing budget for an early-stage company.
The standard FFG Basisprogramm grant covers personnel costs, materials, and certain infrastructure expenses — but not the purchase of a €400,000 analytical instrument. The company either self-funds the purchase (destroying its cash runway), waits for a core facility slot (losing time), or finds a smarter solution.
The smarter solution is to combine FFG funding with equipment sharing. LabWallio's shared instruments are eligible infrastructure for FFG project budgets when used for project-specific research activities. A startup running a flow cytometry programme within an FFG Basisprogramm project can book 40 sessions per year through LabWallio (€10,000–15,000 in total access costs), include those costs as an eligible budget line, and avoid the capital expenditure and depreciation burden of instrument ownership entirely. The same approach works for mass spectrometry, confocal microscopy, ultracentrifugation, and every other instrument category where shared access is available.
The numbers illustrate the advantage clearly. A startup that purchases a flow cytometer for €300,000 carries a 7-year depreciation burden of approximately €43,000 per year, plus service contracts, consumables, and dedicated staff time. A startup that books 40 shared sessions per year at €250 per session pays €10,000 per year, funds it through FFG, and deploys the remaining capital on talent, IP, and clinical development. Over three years, the capital-efficient approach frees up over €100,000 that would otherwise be locked in a depreciating asset.
Practical Application Timeline
The following 12-month timeline reflects what the most successful Austrian life science startups do in their first year of formal funding engagement. It is not a theoretical ideal — it is the sequence that minimises application overhead while maximising probability of success at each stage.
- Months 1–2: aws Pre-Founding Check + FFG Basisprogramm concept note. The aws Pre-Founding Check takes 72 hours and costs nothing. It tells you immediately whether your company and project are eligible for aws instruments and, if so, which ones. In parallel, draft the FFG Basisprogramm concept note. FFG provides a feedback response to concept notes within 4–6 weeks; use that feedback to refine the full application rather than submitting cold.
- Months 2–3: INiTS or LISAvienna application. If your company qualifies for INiTS (technology-intensive, university connection or recent spinoff), submit to the current open call. If not, or in addition, join LISAvienna as a startup member and book a funding navigation session to identify programs you may have missed in your initial research.
- Months 3–6: FFG formal application. Submit the full FFG Basisprogramm application based on the concept note feedback. Include equipment access costs as infrastructure budget line items. Confirm eligibility of LabWallio session costs with your FFG programme manager at concept note stage.
- Months 6–8: aws Double Equity if a private round closes. If you close a private seed or pre-seed round during this period, trigger the aws Double Equity application immediately. The instrument is structured to complement private investment; the sooner you apply after closing a private round, the less dilution you incur in the next round.
- Months 9–12: First FFG disbursement; begin data collection for Horizon EIC Pathfinder. FFG disbursements begin after project approval and reporting milestones. Use the first 12 months of funded research to generate the scientific data that forms the basis of a future EIC Pathfinder application, if your technology has a breakthrough component that is eligible for EU-level deep science funding.
- Ongoing: LabWallio equipment access supports all phases. At €180–320 per instrument-day versus €400–800 per day at core facilities, shared equipment access stretches every funding euro further at every stage of the timeline.
Frequently Asked Questions
What is the best Austrian funding program for a first-time life science startup?
For most first-time founders, the aws Pre-Founding Check is the logical starting point — it is free, takes 72 hours, and gives you an honest assessment of whether your idea is eligible for larger programs. The FFG Basisprogramm is typically the first grant application: it is company-only (no required academic partner), and the €100k–€300k range is realistic for early-stage research. Combine this with INiTS acceleration for mentoring and network access.
Can I use lab equipment sharing costs as a line item in an FFG grant budget?
Yes, with the right documentation. Infrastructure and access costs are eligible under most FFG programs if the expense is directly tied to the research project and you hold a booking confirmation or invoice. LabWallio issues project-coded invoices that meet FFG documentation standards. Confirm eligibility in the concept note phase with your FFG programme manager.
How does Horizon Europe compare to FFG funding for Austrian biotech startups?
The EIC Accelerator is significantly larger (up to €2.5M grant plus equity) but far more competitive and requires a clearer path to market, some traction, and usually 12–18 months of preparation. FFG programs are faster (6–8 months), more accessible, and better suited to companies still in early research. The optimal strategy is to use FFG to build proof of concept and data, then apply to EIC Accelerator once you have validated results.
About the Author
